Waiting time in diagnosis and extirpative surgery and association with survival and stage progression in upper tract urothelial carcinomas
Authors:
- Fredrik LiedbergFLFredrik Liedberg
- Christel HäggströmCHChristel Häggström
- Firas AljaberyFAFiras Aljabery
- Truls GårdmarkTGTruls Gårdmark
- Staffan JahnsonSJStaffan Jahnson
- Tomas JerlströmTJTomas Jerlström
- Viveka StröckVSViveka Ströck
- Karin SöderkvistKSKarin Söderkvist
- Lars HolmbergLHLars Holmberg
- Johannes BobjerJBJohannes Bobjer
Open Access
- 22 September 2025
- journal article
- Published by Wiley in BJUI Compass
- Vol. 6 (9)
Abstract
Objectives: To investigate the association between waiting time and outcomes in patients with upper tract urothelial carcinomas (UTUC).Patients and methods: We studied a population‐based cohort of 858 patients in BladderBaSe 2.0 subjected to extirpative surgery for UTUC 2015–2019 in Sweden. Diagnostic waiting time (from referral to diagnosis, reference <1 week), treatment waiting time (from diagnosis to surgery, reference <5 weeks) and total waiting time (reference 4 weeks was associated with stage progression (OR 2.44 [95% CI 1.00–5.95]), and in patients with UTUC in the ureter, a treatment waiting time between 5 and 10 weeks was associated to worse DSS (HR 2.85 (95% CI 1.03–7.89).Conclusions: In general, shorter care pathways were linked to beneficial survival estimates, yet some estimates may be influenced by selection bias due to prioritizing short waiting times for patients with advanced and/or overt symptomatic tumours. Stage progression with increased waiting time may indicate an underlying causal mechanism.Keywords
Funding Information
- Cancerfonden (CAN 2022/1971, CAN 2023/2807)
- Vetenskapsrådet (2021‐00859)
This publication has 25 references indexed in Scilit:
- Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuriaScandinavian Journal of Urology, 2018
- Impact of surgical waiting time on survival in patients with upper tract urothelial carcinoma: A national cancer database studyUrologic Oncology: Seminars and Original Investigations, 2018
- Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tractUrologic Oncology: Seminars and Original Investigations, 2014
- Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinomaJournal of Surgical Oncology, 2014
- The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative databaseWorld Journal of Urology, 2012
- Upper tract urothelial carcinoma: Impact of time to surgeryUrologic Oncology: Seminars and Original Investigations, 2012
- Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapyBJU International, 2011
- A delay in radical nephroureterectomy can lead to upstagingBJU International, 2010
- The Protective Role of Renal Parenchyma as a Barrier to Local Tumor Spread of Upper Tract Transitional Cell Carcinoma and its Impact on Patient SurvivalJournal of Urology, 2009
- DELAY IN TREATING BLADDER TUMOURSThe Lancet, 1965